Introduction
An infection by Helicobacter pylori (H. pylori) is one of the most important causative factors for chronic active gastritis and peptic ulcers; this particular risk factor has also been documented for gastritis cancer and ranked as a class I carcinogen by the International Research Agency on Cancer (IRAC) (Uemura et al., 2001; Rieder et al., 2003) . In animal experiments, Watanabe et al. (1998) confirmed that an H. pylori infection could induce gastric cancer in Mongolian gerbils. Tokieda et al. (1999) discovered that Mongolian gerbils could be equally induced to suffer from gastric cancer by H. pylori in association with N-methyl-N 0 -nitro-N-nitrosoguanidine (a carcinogenic agent) administered at subthreshold doses; how an infection with H. pylori correlates with the occurrence of gastric cancer remains unclear.
CagA, an important virulence factor of I type of H. pylori, has been proven through epidemiological studies as closely associated with a generation of gastric cancer patients. The titer of CagA antibody in patients with gastric cancer was higher than that in people without gastric cancer; similarly, the titer of CagA antibody in high-risk populations was significantly higher than that in low-risk populations (Zhang et al., 1998) . Compared with CagA-negative H. pylori strains, CagA-positive strains dramatically increased the occurrence of severe gastritis and gastric adenocarcinoma (Tokieda et al., 1999; Enroth et al., 2000; Held et al., 2004; Nobuta et al., 2004) . These studies indicate that CagA may play an important role in the development of gastric cancer. Recently, CagA was discovered to translocate into host cells through a type IV secretion system of H. pylori. The translocated CagA protein is tyrosine-phosphorylated at C-terminus repeat sequence(s) by c-src/Lyn kinase. This reaction strongly disturbs the mitogenactivated protein kinase (MAPK) signaling pathway through its intracellular targets SHP-2 (tyrosine phosphatase containing SH2 homolog) and results in cell proliferation (Odenbreit et al., 2000; Higashi et al., 2002a, b) . Mimuro et al. (2002) found that intracellular CagA via its binding to Grb2 may act as a transducer for stimulating growth factor-like downstream signals, leading to cell morphological changes and proliferation. Amieva et al. (2003) showed that CagA causes a disruption of the apical junctional complex in epithelial cells. Thereby, CagA function promotes cell proliferation and affects cell communication; together, these functions are necessary for a tumor-promoting agent.
CagA may, therefore, play an important role in carcinogenesis of the gastric epithelium as a possible tumor-promoting agent. Reports to this effect, however, have not been documented thus far.
Cell transformation is one of the critical stages in the process of carcinogenesis. Using carcinogenic agents to induce the transformation of normal cells has been a routine method for the study of tumors in vitro (Male et al., 1987; Narayan et al., 2004) . The isolation of normal, primary gastric epithelial cells, however, is not suitable for the study of carcinogenesis mechanisms as these cells rapidly enter into a senescence phase (Terano et al., 1983; Rutten et al., 1996; Smoot et al., 2000) . In our previous study (Zhu et al., 2004a) , we utilized telomerase reverse transcriptase (hTERT) and simian virus 40 (SV40) large T antigen to establish successfully a conditionally immortalized, normal human gastric epithelial cell line (NEC), which also expressed c-src/ Lyn kinase. This cell line cannot form colonies, as evident by our soft-agarose colony test, and the cells do not have oncogenicity, as demonstrated by inoculating nude mice. Additionally, after being transiently transfected with cagA, the cells display a rearrangement of their cytoskeleton (a hummingbird-like phenotype is presented), and the cells were highly sensitive to carcinogenic agents. This evidence indicates that we can employ this cell line as the target cells for the current investigation involving CagA transformation. In the present study, NECs were treated with recombinant pLHCX retrovirus containing cagA (cagA/pLHCX recombinant retrovirus) and 1,2-dimethylhydrazine (DMH) and then screened for transformed colonies through a soft-agarose colony test. Lastly, the difference in CagA expression between transformed and control cells was analysed through Genechip examination. The promotion mechanism underlying the documented CagA transformation is discussed.
Results
Immortalized gastric epithelial cells were transformed by cagA and/or DMH No transformed cell colonies of immortalized NECs emerged in the soft-agarose medium after 28 days, indicating that immortalized NECs do not have a transformation capability in culture. The group transfected with the blank pLHCX vector virus alone did not show transformed cell colonies (Figure 1a ). However, after 14 days in culture, various numbers of small transformed colonies were found in the soft-agarose medium in cagA/pLHCX retrovirus-transfected and/or DMH-treated groups. These colonies presented a villuslike shape and became an agglomerate shape by 28 days (Figure 1b-d) . Transformed colonies from the transfected cagA/pLHCX retrovirus-only culture may result from an increased sensitivity of NECs toward carcinogenic agents in which P53 and Rb proteins are arrested by the SV40 large T antigen (Quartin et al., 1994; Toouli et al., 2002) . Cell colony counts under an inverted microscope revealed that there were more colonies in the group of cagA/pLPCX retrovirus transfection combined with DMH at subthreshold dose (0.1 pg/ml) than in either the cagA/pLHCX retrovirus-transfected group without DMH or the DMH only-treated group (all Po0.05, ANOVA). These results were not different from those of the positive control group (P>0.05, ANOVA) (Figure 2 ). Figure 2 Counting transformed cell colonies. The panel represents the number of colonies scored from the soft-agarose plates. The colonies were counted per cm 3 in each plate. Data are the mean7s.e. of three different determinations. No transformed cell colony of immortalized NECs emerged in soft-agarose medium, and the group transfected with the blank pLHCX vector virus alone did not also show transformed cell colony. However, various numbers of transformed colonies were found in the soft-agarose medium in cagA/pLHCX retrovirus-transfected and/or DMHtreated groups. The number of colonies in the group of cagA/ pLPCX retrovirus transfection, combined with DMH at subthreshold dose (0.1 pg/ml), was significantly more than that in the cagA/ pLHCX retrovirus-transfected group or DMH at subthreshold dose (0.1 pg/ml)-treated group only (all Po0.05, ANOVA) 
CagA protein involvement in cell transformation
To confirm whether CagA was involved in cell transformation, RT-PCR and Western blot analysis were used to detect cagA mRNA and protein in the transformed cells, including CTCs and CDCs. To examine cagA mRNA expression, we designed upstream and downstream primers for cagA of approximately 1500 bp in length, located near the C-terminus. In both CTCs and CDCs, we found a cagA cDNA band, 1500 bp in length (Figure 3a) , conforming to the results of DNA sequencing. Similarly, Western blot results indicated that the CagA protein, with a molecular weight of 121 kDa, was detectable in extracts from CTCs and CDCs but not from DTCs and NECs (Figure 3b ). Expression of CagA protein can also be detected in cell lysates from CTCs and CDCs after more than 30 passages (data not shown).
The interaction between CagA and SHP-2 is the mechanism through which CagA affects cellular signaling. For confirmation of this interaction between CagA and SHP-2, CTCs, CDCs and NECs were lysed with RIPA buffer solution, and then co-immunoprecipitation tests were performed with anti-CagA or anti-SHP-2 antibody-Sepharose 4B beads. The products were detected by Western blot. Results showed that CagA from CTC and CDC lysates were phosphorylated at a tyrosine site and immunoprecipitated with the anti-SHP-2 antibody (Figure 3c and d) . The amount of protein that immunoprecipitated with the antibody was significantly lower than that observed in AGS cells that had been transiently transfected with cagA (data not shown). These findings therefore suggest that CagA plays a role in CTC and CDC transformation.
Erk1/2 MAPK in cagA-transformed cells was constitutively activated
CagA interacts with the MAPK signaling pathway, but it is not known whether CagA can affect MAPK activity in cagA-transformed cells. Thus, we examined whether there is constitutive activation of MAPK in cagAtransformed cells. MAPKs (including extracellular signal-regulated kinase 1/2 (Erk1/2), stress-activated protein kinase (SAPK)/JNK and p38 MAPK) can phosphorylate their specific substrates in vitro. Therefore, nonradioactive-labeled MAPK assay kits were employed to see if and which MAPK activities were detectable in the transformed cells at a population doubling time of 15 and in NECs. We found that only Erk1/2 kinase (p44/42 MAPK) activity in CTCs was significantly higher than that of DTCs or NECs, and Erk1/2 kinase activity in DTCs and NECs did not appear to differ. SAPK/JNK and p38 MAPK activity did not appear to be increased in CTCs relative to NECs (Figure 4a ). These data indicate that Erk1/2 kinase activity in CTCs was constitutively activated, suggesting that CagA may play a role in cell transformation through Erk1/2 MAPK activation.
To identify whether the constitutively activated Erk was a result of an increase of total Erk protein or an increase of phosphorylated Erk, we did a comparative analysis of total Erk and phosphorylated Erk by Western blot. No obvious increases in total Erk among CTCs, DTCs and NECs were found, but phosphorylated Erk was significantly increased in CTCs (Figure 4b ), This selective increase in phosphorylated Erk protein is indicative of Erk1/2 activition.
Erk1/2 MAPK activation by CagA may be independent of Ras activation
The aforementioned results demonstrated that the Erk1/ 2 kinase cascade was activated in cells transformed by cagA. Thus, our next question was which upstream genes of the Ras/Erk/MAPK signaling pathway had changed their transcription and expression. We used an We then selected IQGAP2, R-Ras and B-Raf for further analysis with quantitative real-time PCR and Western blot methodology. In comparison with VICs, the copy numbers for IQGAP2, R-Ras and B-Raf mRNA were dramatically increased (all Po0.01, ANOVA) ( Figure 6a ). The Western blot data were in agreement with the PCR data. Detection by their respective antibodies showed that R-Ras protein increased in both CTCs and DTCs, whereas IQGAP2 and B-Raf proteins were increased only in CTCs (Figure 6b ). The increases in IQGAP2 and B-Raf proteins (particularly B-Raf) were associated with Erk1/2 MAPK activation in CTCs.
Inhibition of Erk activity attenuated the proliferation of cagA-transformed cells
The above results demonstrated that Erk1/2 was constitutively active in CTCs. We therefore sought to determine whether inhibition of Erk1/2 activity could attenuate the proliferation of CTCs. To exclude effects of serum in the medium on Erk kinases, serum-starved conditions were used. Under these conditions, proliferation is dependent on CagA protein rather than serum components. We assessed the effects of inhibiting the Erk kinase cascade on induced DNA synthesis by (Figure 7 ), suggesting that Erk1/2 activity is required for gastric cell transformation. The findings further imply that the Erk1/2 signaling pathway may have useful therapeutic targets for blocking the carcinogenesis of gastric epithelial cells induced by CagA.
Discussion
Tumor-promoting agents exert their effects through inducing changes in gene expression. These agents are known to interfere with cell signaling pathways to alter gene expression (Huang et al., 1999; Chen et al., 1998) .
Abnormal activation of the well-described Ras/MAPK signaling pathway, a pathway that regulates cell growth, is a relatively common phenomenon in tumors (Ostrowski et al., 2000; Salh et al., 2002; AguirreGhiso et al., 2003) . This has been shown in animal models with purposeful chemical mutations of the Ras gene (Sugiyama et al., 1998) . We chose to investigate the tumor-promoting potential of CagA because it can influence the MAPK pathway and promote cell proliferation.
H. pylori, residing in the surface of the gastric epithelium, can continuously translocate CagA into gastric epithelial cells through a specific type IV secretion system (Odenbreit et al., 2000) . To imitate this translocation procedure, we directly transfected a retrovirus with the cagA gene into NECs to produce transfected cells that expressed CagA. In this way, the possible mechanisms by which CagA promotes carcinogenesis could be investigated. Furthermore, it was critical to intervene with CagA in the signal pathway in order to determine whether or not the CagA protein is continuously phosphorylated during the proliferation process of cagA-transformed cells. Selbach et al. (2003) discovered that there was a regulatory system comprised of a negative feedback loop between CagA phosphorylation and c-src activity. In this system, c-src is the kinase that recognizes and activates CagA through phosphorylation. Phosphorylated CagA suppresses c-src expression, which in turn, leads to the inhibition of further phosphorylation of CagA.
In this study, we found that after long-term culture, cagA-transformed cells not only expressed and phosphorylated CagA protein but could also be co-immunoprecipitated with the anti-SHP-2 antibody. This indicates that phosphorylated CagA and the c-src kinase Higashi et al. (2004) found that Erk was activated by CagA protein via a mechanism that involved SHP-2 recruitment and activation in AGS cells. Keates et al. (1999) reported that infection of AGS cells with an H. pylori cag þ strain can induce dosedependent activation of Erk. Erk activation has been reported to play an important role in cell carcinogenesis. For example, an increased and prolonged phosphorylation of Erk in renal epithelial ERC-18 cells was provoked by the tumor promoter 12-o-tetradecanoylphorbol 13-acetate (Kolb and Davis, 2004) . Delayed and sustained activation of Erk MAPK has been found after UVA exposure, which appears to be the most important environmental factor involved in the development of skin cancer. The delayed and sustained Erk activation provides a survival signal to human HaCaT keratinocytes. This may serve as an important mechanism for cell transformation and potential development of UVA exposure-induced skin carcinogenesis in vivo (He et al., 2004) . Similarly, the Erk signaling pathway has been reported to be activated in an animal model of nicotine promotion of tumor growth and neovascularization (Shin et al., 2004) . Furthermore, our Genechip analyses revealed that the transcriptional levels of IQGAP2, R-Ras and B-Raf were altered in cagA-transformed cells. Real-time PCR and Western blot analysis demonstrated that the abnormal activation of the MAPK cascade was not in parallel with the activation of Ras family proteins. IQGAP2, R-Ras and B-Raf are three genes whose changes are relatively obvious in the Ras/Erk/MAPK pathway. Although RRas has about 50% of homology with H, N and K-Ras, their biological functions are different. R-Ras can promote cell apoptosis upon binding to Bcl-2 (FernandezSarabia and Bischoff, 1993; Wang et al., 1995) and directly regulate integrin expression as well as augment cell adhesion. Recent studies have shown that activated R-Ras is able to promote focal adhesion formation and change the intracellular location of the 2b1 integrin. Additionally, persistent activation of R-Ras results in focal adhesion kinase (FAK) and p130Cas phosphorylation. PI3K, Raf, Ral-GDS/Rif/Rgl and Nore1PI3K are all targets of R-Ras, of which PI3K appears to be the most important effector (Keely et al., 1999; Kwong et al., 2003) . Therefore, in cagA-transformed cells, the PI3K pathway may be activated by R-Ras. Since R-Ras was also activated in DMH-transformed cells, its activation does not appear to be specific to CagA stimulation. We speculate that the increases in R-Ras were associated with cell transformation. Cell transformation comes from changes in growth characteristics, such as an absence of cell contact inhibition (anchorageindependent growth), and is an important process in the initial stage of cell carcinogenesis. Therefore, R-Ras may be one of many targets for inhibiting cell transformation (Cox et al., 1994) .
IQGAP2 was initially found expressed only in hepatocyte cell populations. It can activate CDC42 and Rac1, but does not have RasGAP activity. Its amino-acid sequence at the N-terminus has binding sites for F-actin, indicating that it is related to the rearrangement of the cytoskeleton (Bagrodia et al., 1995; Brill et al., 1996; Keely et al., 1997) . The increased expression of IQGAP2 observed in this study suggests that cagA transformation may induce events that involve cytoskeleton rearrangement.
Raf is a serine/threonine protein kinase of the Ras superfamily, a downstream kinase with the function of self-phosphorylation. In mammals, Raf has three isoenzymes: A-Raf, B-Raf and C-Raf (Hindley and Kolch, 2002) . B-Raf is a more effective activator of Erk1/2 than A-Raf or C-Raf, is activated mainly through binding to GTPase Ras and can inhibit cell apoptosis through MEK/Erk activation (Okada et al., 1999; Erhardt et al., 1999) . Additionally, mutational activation of B-Raf is more common than that of the other two isoforms (Calipel et al., 2003; Ikenoue et al., 2003 Ikenoue et al., , 2004 , and, according to recent studies, occurs in 30% of all human tumors (Hubbard, 2004; Wan et al., 2004) . Our study demonstrated that the expression levels of B-Raf mRNA and protein in cagA-transformed cells were significantly higher than those in NECs. Any additional roles of B-Raf activity in cell transformation beyond its interaction with Erk1/2, however, remain to be elucidated. To investigate whether B-Raf is a target of CagA, we are currently testing the use of wild-type CagA and mutated CagA (one tyrosine in EPIYA motif of C-terminus is replaced with phenylalanine by sitedirected mutagenesis) to transfect AGS cells and then detect levels of B-Raf by real-time PCR and Western blot methods.
In summary, changes in IQGAP2 and B-Raf expression levels are associated with an abnormal activation of the MAPK pathway and also appear to be important for NEC transformation. Immortalized NECs transformed by cagA have constitutive activation of the Erk1/2 MAPK cascade independent of Ras activation. Our findings suggest that CagA may play a role in gastric epithelial cell transformation by activation of the Erk MAPK pathway. Translocation of CagA by H. pylori into normal gastric epithelial cells under the challenge of exogenous carcinogenic substances at a subthreshold dose (i.e. as in a contaminated food) may augment Erk1/ 2 MAPK pathway activity and thus promote the occurrence of carcinogenesis. To our knowledge, this is the first study of its kind to investigate the tumorpromoting effects of CagA. It should be noted, however, that the present experiments employed conditionally immortalized human gastric cells as the targets and the Rb/P53 gene was arrested by SV40 large T antigen. Thus, the target cells did not possess the 'checkpoints' of normal cells. Consequently, these cells are more sensitive to exogenous carcinogenic agents. Further investigations with normal cell populations should be undertaken to determine whether CagA participates in transformation under more physiological conditions.
Materials and methods

Reagents
The following were used: pLHCX retrovirus vector (Clontech, USA); high-fidelity PCR master mix (Roche, Germany); endotoxin-free plasmid extraction kit ( Santa Cruz Biotechnology, USA); anti-goat antibody to RRas (C-19; Santa Cruz Biotechnology, USA); anti-goat antibody to IQGAP2 (T-17; Santa Cruz Biotechnology, USA); anti-rabbit/goat/mouse secondary antibody conjugated to horseradish peroxidase (HRP; Beijing Zhongshan Biotechnological, China); ECL substrate (Santa Cruz Biotechnology, USA); anti-BrdU monoclonal antibody (Beijing Zhongshan Biotechnological, China). cagA/pcDNA3.1( þ ) plasmid was constructed in our laboratory as previously described, and it contains three tandem EPIYA motif sequences and one repeated EPIYA motif sequence the amino sequences of which are D-F-D in the D2 region, and it has been confirmed that only one tyrosine site in repeated EPIYA motif sequence can be phosphorylated in AGS cells (Zhu et al., 2004b (Zhu et al., , 2005 .
Cell lines
A PT67-packaged cell line was purchased from Clontech and cultured in DMEM medium (high glycose) supplemented with 10% fetal calf serum. A conditionally immortalized, normal human gastric epithelial cell line (NEC) was established by ectopic expression of telomerase and SV40 large T antigen as previously discussed in our earlier work (Zhu et al., 2004a) . Briefly, stomach epithelial cells were separated from the human fetus using collagenase I and hyaluronidase digestion (this study was approved by the Review Committee of Zhejiang University College of Medicine). Cells were subsequently cultured on a matrix composed of Matrigel. The cultured primary cells were then transfected with a recombinant virus containing either hTERT or SV40 LT (Quaroni and Beaulieu, 1997; Bodnar et al., 1998; Panja, 2000) . Evidence of tumorigenesis was not found in nude mice experiments or in soft-agarose colony tests in vitro.
Recombinant retrovirus with cagA insert
Full-length cagA DNA from a cagA/pcDNA3.1( þ ) plasmid was subcloned into a pLHCX retrovirus vector at the HpaI/ ClaI sites using high-fidelity PCR. After the cagA/pLHCX plasmid was purified by an endotoxin-free plasmid extraction kit, the PT67-packaged cells were transfected with the cagA/ pLHCX plasmid using the CalPhost mammalian transfection kit according to the manufacturer's instructions. At 3 days post-tranfection, cells containing plasmid were selected using hydromycin at a concentration of 250 mg/ml for 14 days. The drug-resistant clones were expanded and the cell culture supernatant, containing the cagA/pLHCX recombinant virus, was filtered through a 0.45 mm filter (low-protein binding). The virus was stored at À701C until further use.
Soft-agarose colony test
Cells were classified into six groups: cells in the first group were transfected with a blank pLHCX vector virus for 24 h; the second group was transfected with the cagA/pLHCX virus for 24 h; the third group was treated with DMH at a subthreshold dose (0.1 pg/ml, which was titered in previous experiments); the fourth group was treated with DMH at a concentration of 0.1 pg/ml for 24 h and subsequently transfected with the cagA/ pLHCX virus for an additional 24 h; the fifth group was treated with DMH at a concentration of 100 000 pg/ml for 24 h; and the sixth group, cultured in RPMI 1640 plus 10% fetal calf serum for 24 h, served as a control. All the cells listed were washed twice with phosphate-buffered saline (PBS) and underwent a 0.25% trypsin-0.1% ethylenediamine tetraacetic acid (EDTA) digest and were then collected for their respective procedures.
An underlay containing an equal mixture of 0.8% agarose (w/v in H 2 O) and double-strength RPMI 1640 plus 20% fetal calf serum was stored at 401C until use. The treated cells (1 Â 10 4 ) were added to this mixture for a final concentration of 10%. A 2 ml portion of the mixture was aliquoted into the wells of six-well tissue culture plates in triplicate. The plates were cooled to 4-81C for 30 min to allow the agarose to set and then incubated for 28 days at 32.51C in a sealed plastic container after being gassed with 5% CO 2 . The plates were examined using the low-power objective of an inverted microscope, and colonies were confirmed using a high-power objective. Colonies were defined as aggregates of more than 40 cells. All assays were performed in triplicate (Whitehead et al., 1999) . Transformed colonies were selected from the agarose gel and expanded. The cagA-transformed cells were named CTCs (cagA-transformed cell); cells transformed with DMH and cagA were termed CDCs (cagA and DMH-transformed cells); and cells transformed with DMH only were called DTCs (DMH-transformed cells).
Immunoblot analysis and immunoprecipitation
For immunoblot analysis, subconfluent CTCs, CDCs, and DTCs at a population doubling time of 15 and NECs were harvested by treating cells with 0.25% trypsin containing 0.1% EDTA in Hank's saline and then terminating the digest with complete medium. Collected cells were washed three times with 10 mM PBS, pH 7.4. Cells were treated with lysis buffer at 1001C for 10 min and centrifuged at 13 000 r.p.m. for 30 min. After protein concentrations were normalized, cell lysates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to polyvinyl difluoride (PVDF) membranes. Blots were blocked with 1% bovine serum albumin (BSA) in Tris-buffered saline containing 0.05% Tween 20 at room temperature for 2 h. Diluted primary antibodies (anti-CagA antibody 1 : 200, anti-B-Raf antibody 1 : 400, anti-R-Ras antibody 1 : 200, anti-total P44/42 antibody 1 : 1000, anti-phosphorylated P44/42 antibody 1 : 1000, inter-reference SV40 large T antigen MoAb 1 : 500, beta-actin antibody 1 : 500) were incubated with the membranes at 371C for 2 h, followed by an anti-rabbit/goat/ mouse secondary antibody conjugated to HRP. Results were visualized with ECL Plus detection reagent and by exposing blots to Fuji medical X-ray film. The images were analysed by Kodak digital Science ID software. For immunoprecipitations, 1 Â 10 6 cells were incubated with RIPA buffer (pH 7.4, 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% Na-deoxycholate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM orthovanadate, 1 mM leupeptin, 1 mM pepstatin) for 120 min at 41C. Cell lysates were centrifuged at 13 000 r.p.m. for 30 min at 41C. For detection of phosphorylated CagA, the supernatant was incubated with anti-CagA antibody at room temperature for 2 h, and then the mixture was pulled down by protein A-agarose beads. For detection of CagA/SHP-2 complex, the supernatant was incubated with anti-SHP-2 antibody-agarose beads while rotating for 2 h at 41C. The immunocomplex was washed three times with ice-cold lysis buffer. Laemmli sample buffer containing b-mercaptoethanol was added and samples were heated to 1001C for 5 min, centrifuged at 13 000 r.p.m. for 5 min and subjected to SDS-PAGE electrophoresis. Gels were transferred to PVDF membranes. The blots were blocked with 1% BSA in Tris-buffered saline with 0.05% Tween 20 at room temperature for 2 h. Diluted anti-CagA antibody (1 : 200) was incubated with the blots for 2 h at 371C, followed by washes and an incubation with anti-rabbit secondary antibody conjugated to HRP. Results were visualized using ECL Plus detection reagent and by exposing the blots to Fuji medical X-ray film.
MAPK assay
To determine MAPK activity of Erk1/2, p38 and SAPK/JNK, subconfluent CTCs and DTCs at a population doubling time of 15 and NECs were used. Media were removed from cultures and cells were rinsed once with ice-cold 10 mM PBS, pH 7.4. Then, 0.5 ml of ice-cold 1 Â cell lysis buffer plus 1 mM PMSF was added to each plate and plates were incubated on ice for 5 min. Cells were scraped off, transferred to appropriate tubes, sonicated on ice and then centrifuged at 13 000 r.p.m. for 10 min at 41C. For every 200 ml volume of the supernatant, 15 ml of immobilized antibody beads was added and the mixtures were incubated overnight at 41C with gentle rocking. The resulting complexes were washed twice with 500 ml of 1 Â cell lysis buffer and the pellet was washed twice with 500 ml of 1 Â kinase buffer. The pellet was resuspended in 50 ml of 1 Â kinase buffer supplemented with 200 mM ATP and an appropriate quantity of kinase substrate (Elk substrate for Erk1/2, ATF-2 for p38 kinase and Phos-c-Jun for SAPK/ JNK). After incubation at 301C for 30 min, reactions were terminated with 25 ml 3 Â SDS sample buffer, vortexed and then microcentrifuged for 30 s. Samples were boiled at 1001C for 2-5 min and 5-15 ml of the samples was loaded onto SDS-PAGE. Samples were electrotransferred to PVDF membranes. The membranes were incubated in 10 ml blocking buffer for 1 h at room temperature, washed three times for 5 min each with 15 ml of 1 Â Tris buffer saline/Tween 20 (TBS/T), and incubated with diluted antibody (1 : 1000 dilution) in 10 ml of primary antibody dilution buffer overnight at 41C. Membranes were washed three times for 5 min, each time with 1 Â TBS/T. Membranes were incubated with HRP-conjugated secondary antibody (1 : 2000) for 1 h at room temperature. After three additional washes, the membranes were incubated in 1 ml of ECL substrate with gentle agitation for 1 min at room temperature, wrapped in plastic wrap and exposed to X-ray film.
Genechip analysis
Total RNAs from CTCs and DTCs at a population doubling time of 12 and VICs (as control cells, at 72 h after infection of blank pLHCX vector virus) were extracted and purified using the RNeasy mini kits. Total RNA (10 mg) was converted into double-stranded cDNA by reverse transcription using the T7-T24 primer set and subjected to phenol/chloroform/isoamyl extraction. For cRNA conversion, the in vitro transcription (IVT) MEGAscriptt T7 kit, along with biotinylated nucleotides, was used. The IVT product was purified using RNeasy mini columns and fragmented. Fragmented IVT product was then hybridized to an Affymetrix U95Av2 Genechip and wash steps were performed as suggested by the manufacturer. Each hybridized Affymetrix Genechip array was scanned with an argon ion laser scanner at 570 nm. Initial absolute and comparative analysis on the resulting data images was performed with Affymetrix custom image analysis software (Genechip version 3.1). The differences between VIC cells and transformed cells were compared by unilateral and bilateral ANOVA statistical analysis. The detection specificity of the genechip was 1/100 000 copies. Expressions of the target genes were judged to increase if the value was X1.5 times that of the VIC cells and to decrease if it was p0.5 times that of VIC cells. The false gene information resulted, as per http://masker.nci. nih.gov/ev; the gene analytic data were from the GenBank database: http://www.ncbi.nim.nih.gov or the Gene Cards database: http://bioinf.weizmann.ac.il/cards/index.html, except as indicated in the references.
Quantitative real-time PCR
Duplex real-time PCR (target gene and GAPDH as reference gene) in 96-well optical plates was performed with reversetranscribed RNA derived from different cells using TaqMan technology and analysed on ABI Prism PE7700 Sequence Detection System according to standard protocols. Data were normalized to internal GAPDH levels and represented as relative expression (E) whereas delta Ct (DCt) indicated the threshold difference between GAPDH and the target gene. Specific PCR primer pairs and fluorogenic probes were used for genes of interest under the following PCR conditions: 501C for 2 min, and then 951C for 
Immunocytochemical determination of DNA synthesis
For determination of DNA synthesis, subconfluent CTCs, DTCs, NECs and VICs were harvested by treatment with 0.25%. trypsin containing 0.1% EDTA in Hank's saline. The digestion was terminated with complete medium. Subsequently, all cells were transferred to serum-free media and cultured overnight with addition of 30 mM PD98059 (Erk1/2 inhibitor) or 30 mM DMSO (as a control). The medium was supplemented with 10 mM BrdU 18 h later. The cells were fixed in acetone for 30 min at room temperature, pretreated with 1% Triton X-100 and chilled on ice for 30 min. The cells were then washed twice with 10 mM PBS (pH 7.4) and blocked with nonimmune serum. Cells were incubated with a primary mouse monoclonal antibody against BrdU dilution at room temperature for 60 min, followed by incubation with a biotinylated sheep anti-mouse IgG secondary antibody. Immunolabeling was amplified by subsequent incubation with a peroxidasestreptavidin conjugate and visualized by a reaction with DAB substrate. The number of positive cells per 200 cells was counted and data were recorded as a percentage of total cells that were positively labeled. These data were used to calculate the percentage inhibition of DNA synthesis in treated cells relative to control cells.
Abbreviations DMH, 1,2-dimethylhydrazine; SHP-2, tyrosine phosphatase containing SH2 homolog; SV40 LT, simian virus large T antigen; IVT, in vitro transcription; PBS, phosphate-buffered saline; TBS/T, Tris buffer saline/Tween 20; PMSF, phenylmethylsulfonyl fluoride; BSA, bovine serum albumin; EDTA, ethylenediamine tetraacetic acid; MAPK, mitogen-activated protein kinase; Erk1/2, extracellular signal-regulated kinase 1/ 2; SAPK, stress-activated protein kinase; DMSO, dimethyl sulfoxide.
